AnaBios
![](https://i0.wp.com/3rc.org/wp-content/uploads/2024/03/ANABIOS-LOGO-F.jpg?fit=450%2C195&ssl=1)
AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies, including superior quality human tissue samples and functional assays focused, as well as human primary cells through its subsidiary Cell Systems.
BiomimX
![](https://i0.wp.com/3rc.org/wp-content/uploads/2022/01/Screen-Shot-2022-01-18-at-3.18.40-PM.png?fit=575%2C253&ssl=1)
BiomimX develops the next generation of beating organs-on-chips. uBeat® Platforms and connected hardware provide 3D miniaturized constructs with a tunable mechanical stimulation to model human organs’ function and diseases. uBeat® products and customized drug screening services are available.
Newcells Biotech
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/08/Newcells-e1658253162581.jpg?fit=400%2C174&ssl=1)
Newcells Biotech uses 3D in vitro modelling expertise to develop nephrotoxicity and renal transporter assays that most accurately predict in vivo outcomes, as well as producing fully developed hiPSC-derived Retinal Organoids.
AlveoliX
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/06/AlveoliXS2.png?fit=800%2C336&ssl=1)
AlveoliX is a Swiss-based organ-on-chip company. Our product is comprised of different hardware components and the easy-to-handle organ-on-chip consumable AX12. On the AX12 healthy and diseased biomodels can be created to study drug safety and efficacy and to answer fundamental research questions.
InSphero
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/InSpheroS2.png?fit=800%2C336&ssl=1)
InSphero is the pioneer of industrial-grade, 3D-microtissue-based assay solutions and scaffold-free 3D organ-on-a-chip technology. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and immuno oncology.
Lena Biosciences
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/LenaS2.png?fit=800%2C336&ssl=1)
Lena Biosciences offers Perfused Organ Panel MPS with a Blood Substitute hemoglobin analog that yields a log-fold increase in CYP450 activity in primary human hepatocytes to identify mitotoxic metabolites and DILI. Services focus on efficacy and toxicity in liver, brain, tumor, and blood models.
Hesperos Inc.
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/HesperosS2-1.png?fit=800%2C336&ssl=1)
Hesperos is accelerating drug discovery by providing safety and efficacy testing services using its Human-on-a-Chip, microphysiological system. This breakthrough technology enables unprecedented preclinical insight bringing better therapies to patients faster without the need for animal testing.
CN Bio
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/CN-BioS2.png?fit=800%2C336&ssl=1)
CN Bio is a leading bioengineering company specializing in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines.
Altis Biosystems
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/AltisS2-1.png?fit=800%2C336&ssl=1)
Altis Biosystems has developed a stem cell platform that recreates the human intestinal epithelium, using proliferative stem cells and terminally differentiated cells. These cells are sourced from transplant-grade intestine. It is a high-throughput format, ideal for drug screening.